AMENDMENT NO. 1 TO COLLATERAL AGREEMENTCollateral Agreement • February 26th, 2019 • Vivus Inc • Pharmaceutical preparations
This AMENDMENT NO. 1 TO COLLATERAL AGREEMENT, dated as of July 6, 2018 (this “Amendment”), is entered into by and between VIVUS, Inc., a Delaware corporation (“Issuer”), U.S. Bank National Association, as Trustee (“Trustee”) and U.S. Bank National Association, as Collateral Agent (“Collateral Agent”).
ContractVivus Inc • February 26th, 2019 • Pharmaceutical preparations
*** Indicates material that was omitted and for which confidential treatment was requested. all such omitted material was filed separately with the securities and exchange commission pursuant to rule 24B-2 promulgated under the securities exchange act of 1934, as amended.
AMENDMENT NO. 2 TO COLLATERAL AGREEMENTCollateral Agreement • February 26th, 2019 • Vivus Inc • Pharmaceutical preparations
This AMENDMENT NO. 2 TO COLLATERAL AGREEMENT, dated as of October 11, 2018 (this “Amendment”), is entered into by and between VIVUS, Inc., a Delaware corporation (“Issuer”), U.S. Bank National Association, as Trustee (“Trustee”) and U.S. Bank National Association, as Collateral Agent (“Collateral Agent”).
AMENDMENT NO. 3 TO COLLATERAL AGREEMENTCollateral Agreement • February 26th, 2019 • Vivus Inc • Pharmaceutical preparations
This AMENDMENT NO. 3 TO COLLATERAL AGREEMENT, dated as of December 7, 2018 (this “Amendment”), is entered into by and between VIVUS, Inc., a Delaware corporation (“Issuer”), U.S. Bank National Association, as Trustee (“Trustee”) and U.S. Bank National Association, as Collateral Agent (“Collateral Agent”).
